The Fort Worth Press - Once-taboo ketamine booms for US at-home mental care

USD -
AED 3.673039
AFN 69.000382
ALL 89.101678
AMD 387.749826
ANG 1.804889
AOA 928.475981
ARS 962.7414
AUD 1.46872
AWG 1.8
AZN 1.710825
BAM 1.753412
BBD 2.022028
BDT 119.677429
BGN 1.76065
BHD 0.376814
BIF 2894
BMD 1
BND 1.293151
BOB 6.920294
BRL 5.425499
BSD 1.001511
BTN 83.756981
BWP 13.175564
BYN 3.277435
BYR 19600
BZD 2.018612
CAD 1.356395
CDF 2871.000085
CHF 0.84791
CLF 0.033735
CLP 930.859741
CNY 7.067977
CNH 7.07284
COP 4165.25
CRC 518.757564
CUC 1
CUP 26.5
CVE 99.250254
CZK 22.491396
DJF 177.72004
DKK 6.684975
DOP 60.203552
DZD 132.341911
EGP 48.534057
ERN 15
ETB 117.497487
EUR 0.896196
FJD 2.2003
FKP 0.761559
GBP 0.753255
GEL 2.729512
GGP 0.761559
GHS 15.701624
GIP 0.761559
GMD 68.504127
GNF 8652.498216
GTQ 7.741513
GYD 209.457218
HKD 7.793945
HNL 24.949828
HRK 6.799011
HTG 131.977784
HUF 353.230215
IDR 15202
ILS 3.750095
IMP 0.761559
INR 83.61045
IQD 1310
IRR 42092.504652
ISK 136.490277
JEP 0.761559
JMD 157.339131
JOD 0.708698
JPY 142.851991
KES 128.999539
KGS 84.275012
KHR 4069.999863
KMF 441.350282
KPW 899.999433
KRW 1329.045033
KWD 0.30494
KYD 0.834476
KZT 479.593026
LAK 22085.000237
LBP 89268.117889
LKR 304.846178
LRD 194.249486
LSL 17.502706
LTL 2.95274
LVL 0.60489
LYD 4.745018
MAD 9.695018
MDL 17.473892
MGA 4555.000175
MKD 55.200186
MMK 3247.960992
MNT 3397.999955
MOP 8.038636
MRU 39.715032
MUR 45.869795
MVR 15.36002
MWK 1736.00021
MXN 19.317199
MYR 4.218972
MZN 63.849846
NAD 17.499915
NGN 1640.319638
NIO 36.769417
NOK 10.503135
NPR 134.027245
NZD 1.604145
OMR 0.384961
PAB 1.001511
PEN 3.745005
PGK 3.914203
PHP 55.562997
PKR 278.098209
PLN 3.83075
PYG 7817.718069
QAR 3.64025
RON 4.457506
RSD 104.909468
RUB 92.170071
RWF 1342
SAR 3.752548
SBD 8.306937
SCR 13.623023
SDG 601.497767
SEK 10.16481
SGD 1.292595
SHP 0.761559
SLE 22.847303
SLL 20969.494858
SOS 570.999811
SRD 29.852962
STD 20697.981008
SVC 8.762579
SYP 2512.529936
SZL 17.503112
THB 33.1435
TJS 10.644256
TMT 3.5
TND 3.024035
TOP 2.3498
TRY 34.084935
TTD 6.806508
TWD 31.924966
TZS 2724.999896
UAH 41.500415
UGX 3718.795247
UYU 41.141269
UZS 12735.000116
VEF 3622552.534434
VES 36.755455
VND 24580
VUV 118.722009
WST 2.797463
XAF 588.099177
XAG 0.032507
XAU 0.000387
XCD 2.70255
XDR 0.742235
XOF 587.50055
XPF 107.297095
YER 250.324957
ZAR 17.510415
ZMK 9001.198401
ZMW 26.062595
ZWL 321.999592
  • RBGPF

    3.5000

    60.5

    +5.79%

  • RELX

    0.7600

    48.13

    +1.58%

  • RYCEF

    0.4000

    6.95

    +5.76%

  • CMSC

    0.0650

    25.12

    +0.26%

  • RIO

    2.2700

    65.18

    +3.48%

  • BTI

    -0.3100

    37.57

    -0.83%

  • NGG

    -1.2200

    68.83

    -1.77%

  • BP

    0.3300

    32.76

    +1.01%

  • GSK

    -0.8100

    41.62

    -1.95%

  • AZN

    0.3200

    78.9

    +0.41%

  • SCS

    -0.8000

    13.31

    -6.01%

  • BCC

    7.6300

    144.69

    +5.27%

  • VOD

    -0.1700

    10.06

    -1.69%

  • CMSD

    0.0300

    25.01

    +0.12%

  • BCE

    -0.4200

    35.19

    -1.19%

  • JRI

    -0.0400

    13.4

    -0.3%

Once-taboo ketamine booms for US at-home mental care
Once-taboo ketamine booms for US at-home mental care

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement –- ketamine -– shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

Text size:

A pandemic-spurred easing of prescription rules helped fuel a jump in telemedicine offerings of ketamine, an anesthetic that was once a taboo party drug but has become a buzzed-about tool against depression.

Yet long-term, large-scale studies of ketamine's medical impact are limited, leaving some experts concerned that an unregulated online boom could result in mishaps or a regulatory crackdown.

"This has to be rolled out slowly," said Boris Heifets, a Stanford University assistant professor of anesthesiology. "The risk is that we are scaling the fix but not the solution, which is a much more integrated approach to mental health."

Ketamine has been available in the United States since the 1970s as an anesthetic called a "dissociative" because of the hallucinogenic effects that have helped make it a rave culture drug.

It's legal for US doctors to prescribe, while some other psychedelics getting renewed attention for mental health uses like LSD or MDMA (also called ecstasy) are classified as having no medical utility and a high risk for abuse.

In this context, recent years have seen an uptick in clinics offering in-person intravenous ketamine treatments for depression, anxiety or chronic pain, though regulations and practices vary across American states.

- Ketamine 'babysitter' -

Then came the pandemic, which resulted in US authorities allowing doctors to remotely prescribe drugs like ketamine that previously required an in-person visit.

An increasing number of companies, some already doing in-clinic treatments, began offering to evaluate clients online and to send the drugs for home use to approved candidates.

Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.

"If you actually drill down on the sort of potentials for abuse here, you realize of course they exist, but we're creating a standard of care to make that quite unlikely," he told AFP.

For example, he noted clients are instructed to have an adult "babysitter" watch over them for the roughly 90 minutes the drug experience lasts, and he reasoned that people simply looking for ketamine could get it cheaper on the street.

Clients of the service, which costs $1,250 for a package providing six ketamine experiences, are encouraged but not obligated to couple it with therapy, Cappello said.

"The at-home telemedicine model, I would argue, is actually safer and more effective for patients," allowing more patients "to actually take advantage of these therapies," he added.

Heifets, the Stanford researcher, noted that making ketamine more available carries risks -- including the chances that authorities would tighten access if an at-home treatment resulted in some sort of tragedy.

- 'Change your life' -

US regulators in 2019 approved a type of ketamine specifically for adults with treatment-resistant depression, though with stringent rules like requiring patients to be monitored by a health care provider for at least two hours after their dose.

Americans have "a hair trigger for problem-solving through litigation," Heifets noted of the potential for lawsuits if things go wrong.

He was part of a team that analyzed the real-world effectiveness of intravenous ketamine therapy -- which can involve higher doses than the at-home services –- and reported most patients improved, though about eight percent said depressive symptoms worsened after treatment.

"We have very, very little evidence for our understanding of how effective ketamine is for depression at scale," he added.

Yet for people like 36-year-old New Yorker Philip Markle, who underwent an at-home treatment with a company called Mindbloom, ketamine is a profoundly useful tool.

Over his long battle with depression, the performer and comedian has tried medication, psychedelics like LSD, and talk therapy since the age of 12, but found something unique in ketamine.

Rather than the short-lived sense of change other treatments provided, ketamine imparted a sense of clarity and of helpful self-acceptance -– not the heavy effects he'd experienced with other psychedelics.

"It felt like if any drug could be administered through the mail, and you could do a psychedelic that could change your life, on your own, this would be the one," he told AFP.

S.Weaver--TFWP